Evaluating the incidence of spinal cord injury after spinal cord stimulator implant: an updated retrospective review

N. Hussain, Jatinder S. Gill, Jarod Speer, M. Abdel-Rasoul, A. Abd-Elsayed, Safdar N. Khan, A. Nguyen, Thomas T Simopoulos, T. Weaver
{"title":"Evaluating the incidence of spinal cord injury after spinal cord stimulator implant: an updated retrospective review","authors":"N. Hussain, Jatinder S. Gill, Jarod Speer, M. Abdel-Rasoul, A. Abd-Elsayed, Safdar N. Khan, A. Nguyen, Thomas T Simopoulos, T. Weaver","doi":"10.1136/rapm-2021-103307","DOIUrl":null,"url":null,"abstract":"Introduction While spinal cord stimulator implant is an increasingly safe procedure, one of the most feared complications is spinal cord injury. Still, literature regarding its incidence remains highly variable. This retrospective analysis aims to evaluate the incidence of spinal cord injury after spinal cord stimulator implant using a large-scale claims database. Methods The PearlDiver-Mariner database of national all payer claims was used to identify patients who underwent spinal cord stimulator implant (percutaneous or paddle) and developed subsequent spinal cord injury within 45 days. The primary outcome was to determine the overall incidence of spinal cord injury after spinal cord stimulator implant. Secondary outcomes included an evaluation of potential factors associated with developing spinal cord injury using univariable and multivariable regression analysis. Results A total of 71,172 patients who underwent a spinal cord stimulator implant were included in the analysis, of which 52,070 underwent percutaneous and 19,102 underwent paddle spinal cord stimulator lead implant. The overall incidence of spinal cord injury after spinal cord stimulator implant (any lead type) was found to be 0.42% (302 patients). The incidence of spinal cord injury after percutaneous and paddle lead implants did not differ at 0.45% (233 patients) and 0.36% (69 patients)(p=0.12), respectively. Overall, variables associated with a significantly increased OR (95% confidence interval) of developing spinal cord injury included male gender by 1.31 times (1.04 to 1.65)(p=0.02); having a claim for low molecular weight heparin within 30 days by 3.99 times (1.47 to 10.82)(p<0.01); a diagnosis for osteoporosis within 1 year by 1.75 times (1.15 to 2.66)(p<0.01); and a diagnosis of cervical or thoracic spinal canal stenosis within 1 year by 1.99 (1.37 to 2.90)(p<0.001) and 4.00 (2.63 to 6.09)(p<0.0001) times, respectively. Conclusions Overall, our results support the notion that spinal cord stimulator implant continues to be a safe procedure for chronic pain patients. However, risk factor mitigation strategies for the prevention of spinal cord injury after spinal cord stimulator implant should be undertaken prior to performing the procedure.","PeriodicalId":21046,"journal":{"name":"Regional Anesthesia & Pain Medicine","volume":"20 1","pages":"401 - 407"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regional Anesthesia & Pain Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/rapm-2021-103307","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Introduction While spinal cord stimulator implant is an increasingly safe procedure, one of the most feared complications is spinal cord injury. Still, literature regarding its incidence remains highly variable. This retrospective analysis aims to evaluate the incidence of spinal cord injury after spinal cord stimulator implant using a large-scale claims database. Methods The PearlDiver-Mariner database of national all payer claims was used to identify patients who underwent spinal cord stimulator implant (percutaneous or paddle) and developed subsequent spinal cord injury within 45 days. The primary outcome was to determine the overall incidence of spinal cord injury after spinal cord stimulator implant. Secondary outcomes included an evaluation of potential factors associated with developing spinal cord injury using univariable and multivariable regression analysis. Results A total of 71,172 patients who underwent a spinal cord stimulator implant were included in the analysis, of which 52,070 underwent percutaneous and 19,102 underwent paddle spinal cord stimulator lead implant. The overall incidence of spinal cord injury after spinal cord stimulator implant (any lead type) was found to be 0.42% (302 patients). The incidence of spinal cord injury after percutaneous and paddle lead implants did not differ at 0.45% (233 patients) and 0.36% (69 patients)(p=0.12), respectively. Overall, variables associated with a significantly increased OR (95% confidence interval) of developing spinal cord injury included male gender by 1.31 times (1.04 to 1.65)(p=0.02); having a claim for low molecular weight heparin within 30 days by 3.99 times (1.47 to 10.82)(p<0.01); a diagnosis for osteoporosis within 1 year by 1.75 times (1.15 to 2.66)(p<0.01); and a diagnosis of cervical or thoracic spinal canal stenosis within 1 year by 1.99 (1.37 to 2.90)(p<0.001) and 4.00 (2.63 to 6.09)(p<0.0001) times, respectively. Conclusions Overall, our results support the notion that spinal cord stimulator implant continues to be a safe procedure for chronic pain patients. However, risk factor mitigation strategies for the prevention of spinal cord injury after spinal cord stimulator implant should be undertaken prior to performing the procedure.
评估脊髓刺激器植入后脊髓损伤的发生率:一项最新的回顾性综述
虽然脊髓刺激器植入是一种越来越安全的手术,但最可怕的并发症之一是脊髓损伤。尽管如此,关于其发病率的文献仍然高度可变。本回顾性分析旨在利用大型索赔数据库评估脊髓刺激器植入后脊髓损伤的发生率。方法使用PearlDiver-Mariner全国所有付款人索赔数据库,识别在45天内接受脊髓刺激器植入(经皮或桨式)并发生脊髓损伤的患者。主要结果是确定脊髓刺激器植入后脊髓损伤的总体发生率。次要结果包括使用单变量和多变量回归分析评估与发生脊髓损伤相关的潜在因素。结果共纳入71,172例脊髓刺激器植入患者,其中52,070例经皮脊髓刺激器植入,19,102例桨形脊髓刺激器铅植入。脊髓刺激器(任何铅型)植入后脊髓损伤的总发生率为0.42%(302例)。经皮铅植入和桨叶铅植入后脊髓损伤发生率无差异,分别为0.45%(233例)和0.36%(69例)(p=0.12)。总体而言,与发生性脊髓损伤OR(95%置信区间)显著增加相关的变量包括男性,前者是后者的1.31倍(1.04 ~ 1.65)(p=0.02);30天内索赔低分子肝素的数量增加3.99倍(1.47 ~ 10.82)(p<0.01);1年内诊断为骨质疏松的比例为1.75倍(1.15 ~ 2.66)(p<0.01);而1年内诊断出颈、胸椎椎管狭窄者分别高出1.99(1.37 ~ 2.90)倍(p<0.001)和4.00(2.63 ~ 6.09)倍(p<0.0001)。结论:总的来说,我们的结果支持脊髓刺激器植入仍然是慢性疼痛患者的安全手术。然而,脊髓刺激器植入后预防脊髓损伤的风险因素缓解策略应在手术前实施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信